Literature DB >> 5824854

Gas chromatographic determination of the secondary amine alprenolol, as its trifluoroacetyl derivative, at nanogram levels in biological fluids.

M Ervik.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5824854

Source DB:  PubMed          Journal:  Acta Pharm Suec        ISSN: 0001-6675


× No keyword cloud information.
  8 in total

1.  Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockade.

Authors:  P Collste; K Haglund; M Frisk-Holmberg; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953

2.  Importance of "first-pass elimination" for interindividual differences in steady-state concentrations of the adrenergic beta-receptor antagonist alprenolol.

Authors:  G Alván; M Lind; B Mellström; C von Bahr
Journal:  J Pharmacokinet Biopharm       Date:  1977-06

3.  Steady-state plasma concentrations of alprenolol in man.

Authors:  M D Rawlins; P Collste; M Frisk-Holmberg; M Lind; J Ostman; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1974-08-23       Impact factor: 2.953

4.  Comparison of two adrenergic beta-receptor blocking agents, alprenolol and propranolol, in treatment of angina pectoris.

Authors:  D J Heterington; M B Comerford; G Nyberg; E M Besterman
Journal:  Br Heart J       Date:  1973-03

5.  Lack of biological interaction of alprenolol and salicylate in man.

Authors:  G Johnsson; C G Regårdh; L Sölvell
Journal:  Eur J Clin Pharmacol       Date:  1973-06       Impact factor: 2.953

6.  Central haemodynamic effects in man of intravenous d-alprenolol during rest and exercise.

Authors:  L G Ekelund; A Melcher; L Orö
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

7.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

8.  Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. II. Relationship to its effect on blood pressure and plasma renin activity.

Authors:  P Collste; K Haglund; M Frisk-Holmberg; M L Orme; M D Rawlins; J Ostman
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.